Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Oct 23, 2026
144 Oct 23, 2026
144 Oct 23, 2026
8-K Oct 21, 2026 8-K
8-K Oct 15, 2026 8-K
4 Oct 2, 2026 PRIMARY DOCUMENT
4 Sep 11, 2026 FORM 4
8-K Sep 11, 2026 8-K
8-K Sep 9, 2026 8-K
4 Sep 8, 2026 FORM 4
4 Sep 8, 2026 FORM 4
144 Sep 3, 2026
EFFECT Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
CORRESP Aug 13, 2026
UPLOAD Aug 12, 2026
S-3 Aug 7, 2026 S-3
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
4 Jul 27, 2026 FORM 4
4 Jul 27, 2026 FORM 4
4 Jul 27, 2026 FORM 4
4 Jul 27, 2026 FORM 4
← Newer Page 1 of 43 · 1060 filings Older →